Beneficios de la optimización del tratamiento antidiabético al alta en los pacientes ingresados en una Unidad de Corta Estancia
ISSN: 2171-9020
Any de publicació: 2018
Títol de l'exemplar: Edoxaban para trombosis asociadas al cáncer
Volum: 1
Número: 38
Tipus: Article
Altres publicacions en: MPG Journal
Resum
A significant amount of patients treated in the Emergencypresent Diabetes Mellitus in their medical history records. An appropriate antidiabetic treatment after discharge from a Short-Stay Unit (SSU) after a hyperglycemic crisiscould reduce adverse events in the following three months.
Referències bibliogràfiques
- Alonso G, Escudero JM. The emergency department short stay unit and the hospital at home as alternatives to standard inpatients hospitalisation. An Sist Sanit Navar. 2010;33(Supl. 1):97-106.
- Falciglia M, Freyberg RW, Almenoff PL, DÀlessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37:3001-9.
- Glynn N, Owens L, Bennett K, Healy ML, Silke B. Glucose as a risk predictor in acute medical emergency admissions. Diabetes Res Clin Pract. 2014;103:119-26.
- Stratton IM, Alder AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS35): prospective observational study. BMJ. 2000;321:405-12.
- The Nice-SUGAR investigators. Intensive versus conventional glucose control in critical ill patients. N Engl J Med. 2009;360:1283-97.